Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.97
Delayed Data
As of 3:57pm ET
 -0.025 / -0.50%
Today’s Change
3.42
Today|||52-Week Range
6.31
+18.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues8.7M69.4M11.7M15.6M
 
 
 
 
 
Depreciation And Amortization565.0K2.1M1.1M1.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses45.4M58.8M66.4M63.1M
 
 
 
 
 
Research And Development28.2M37.6M42.6M35.1M
 
 
 
 
 
Total Operating Expenses46.0M60.9M67.5M64.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-37.3M8.5M-55.8M-49.0M
 
 
 
 
 
Extraordinary Credit0.004.6M0.005.8M
 
 
 
Extraordinary Charge-2.0M0.00-2.6M-23.2M
 
 
 
 
Interest Expense On Debt0.00800.0K5.1M5.0M
 
 
 
 
Other Expenses0.00-34.0K-247.0K-21.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.3M12.6M-62.7M-69.3M
 
 
 
 
 
Income Taxes-133.0K-1.8M-11.7M-1.6M
 
 
 
 
 
Minority Interest-7.0K-73.0K0.000.00
 
 
 
Net Income-39.1M10.8M-51.0M-67.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.7M70.0M70.3M77.9M
 
 
 
 
 
Shares To Calculate EPS Diluted69.7M70.2M70.3M77.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.56$0.15-$0.73-$0.87
 
 
 
 
 
EPS Diluted-$0.56$0.15-$0.73-$0.87